Cargando…

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors

SIMPLE SUMMARY: Endometrial (EC) and cervical cancers (CC) do not respond well to chemotherapy and alternative therapeutic options are lacking. Recently, EC and CC patients’ outcome were improved thanks to immunotherapy-based treatments leading to their approval in the management of these diseases....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lainé, Alexandra, Gonzalez-Lopez, Andrea M., Hasan, Uzma, Ohkuma, Ryotaro, Ray-Coquard, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093320/ https://www.ncbi.nlm.nih.gov/pubmed/37046702 http://dx.doi.org/10.3390/cancers15072042

Ejemplares similares

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
por: Ménétrier-Caux, Christine, et al.
Publicado: (2019)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
por: van der Woude, Hannah, et al.
Publicado: (2022)

Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma
por: Kousar, Kousain, et al.
Publicado: (2022)

Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
por: Mahdi, Haider, et al.
Publicado: (2023)

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
por: Schepisi, Giuseppe, et al.
Publicado: (2021)

Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear
por: Ng, Joanna K. M., et al.
Publicado: (2023)

Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy
por: Zhan, Lei, et al.
Publicado: (2020)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Imaging of endometrial and cervical cancer
por: Patel, Shilpa, et al.
Publicado: (2010)

Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses
por: Li, Yimin, et al.
Publicado: (2021)

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History
por: Brahmi, Mehdi, et al.
Publicado: (2020)

Rare case of uterine neoplasm: cervical sarcoma with endometrial carcinoma
por: Ma, Ying, et al.
Publicado: (2019)

Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
por: Bareham, Bethany, et al.
Publicado: (2021)

The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways
por: Birrer, Michael J., et al.
Publicado: (2022)

Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
por: Zhang, He, et al.
Publicado: (2023)

Radiomics in cervical and endometrial cancer
por: Manganaro, Lucia, et al.
Publicado: (2021)

Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer
por: Wei, Wei, et al.
Publicado: (2023)

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma
por: Wu, Zhicheng, et al.
Publicado: (2022)

Signatures of immune cell infiltration for predicting immune escape and immunotherapy in cervical cancer
por: Chen, Fuxing, et al.
Publicado: (2023)

New developments in treatment of ovarian carcinoma: focus on trabectedin
por: Cassier, Philippe A, et al.
Publicado: (2010)

Immunotherapy in endometrial cancer: new scenarios on the horizon
por: Di Tucci, Chiara, et al.
Publicado: (2019)

Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015)

Immunotherapy in endometrial cancer: rationale, practice and perspectives
por: Cao, Wenyu, et al.
Publicado: (2021)

Vaginal mucositis related to immunotherapy in endometrial cancer
por: Patel, Jharna M., et al.
Publicado: (2021)

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
por: Xu, Liangliang, et al.
Publicado: (2022)

Interaction Between Chronic Endometritis Caused Endometrial Microbiota Disorder and Endometrial Immune Environment Change in Recurrent Implantation Failure
por: Chen, Peigen, et al.
Publicado: (2021)

Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin
por: Lin, Douglas I., et al.
Publicado: (2020)

Integrated analysis of immune-related genes in endometrial carcinoma
por: Wang, Yiru, et al.
Publicado: (2020)

Single-Cell Profiling of the Immune Atlas of Tumor-Infiltrating Lymphocytes in Endometrial Carcinoma
por: Jiang, Fang, et al.
Publicado: (2022)

The Revolution of Immunotherapy in Gynecological Cancers: The Lazarus Effect in Endometrial Cancer
por: Ducceschi, Monika, et al.
Publicado: (2023)

Immune Cytolytic Activity for Comprehensive Insights of the Immune Landscape in Endometrial Carcinoma
por: Chen, Qiang, et al.
Publicado: (2022)

Recurrent or primary metastatic cervical cancer: current and future treatments
por: Gennigens, C., et al.
Publicado: (2022)

Predictors of uncommon location of sentinel nodes in endometrial and cervical cancers
por: Kadan, Yfat, et al.
Publicado: (2021)

Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing
por: Guo, Yu-e, et al.
Publicado: (2021)

Differential expression of MUC genes in endometrial and cervical tissues and tumors
por: Hebbar, Vidya, et al.
Publicado: (2005)

Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
por: Liang, Deku, et al.
Publicado: (2021)

FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma
por: Wang, Zhe, et al.
Publicado: (2022)

Coexisting Brenner Tumor and Endometrial Carcinoma
por: Sharma, Mitakshara, et al.
Publicado: (2017)

Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4k09be0ks3vgpvi6n3qholmk2h